A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties

被引：31

作者：

Blome, Sandra ^{[1
]}

Wernike, Kerstin ^{[1
]}

Reimann, Ilona ^{[1
]}

Koenig, Patricia ^{[1
]}

Moss, Claudia ^{[1
]}

Beer, Martin ^{[1
]}

机构：

[1] Friedrich Loeffler Inst, Inst Diagnost Virol, Suedufer 10, D-17493 Greifswald, Germany

来源：

VETERINARY RESEARCH | 2017年 / 48卷

关键词：

LINKED-IMMUNOSORBENT-ASSAY; PRE-REGISTRATION EFFICACY; C-STRAIN VACCINE; CANDIDATE CP7-E2ALF; ORAL IMMUNIZATION; WILD BOAR; GENETIC DIFFERENTIATION; RT-PCR; VIRUS; CHALLENGE;

D O I：

10.1186/s13567-017-0457-y

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Due to its impact on animal health and pig industry, classical swine fever (CSF) is still one of the most important viral diseases of pigs. To control the disease, safe and highly efficacious live attenuated vaccines exist for decades. However, until recently, the available live vaccines did not allow a serological marker concept that is essentially important to circumvent long- term trade restrictions. In 2014, a new live attenuated marker vaccine, - Suvaxyn (R) CSF Marker (Zoetis), was licensed by the European Medicines Agency. This vaccine is based on pestivirus chimera "CP7_E2alf" that carries the main immunogen of CSF virus "Alfort/187", glycoprotein E2, in a bovine viral diarrhea virus type 1 backbone ("CP7"). This review summarizes the available data on design, safety, efficacy, marker diagnostics, and its possible integration into control strategies.

引用

页数：10

共 50 条

[21] Classical swine fever (CSF) marker vaccine - Trial III. Evaluation of discriminatory ELISAs
Floegel-Niesmann, G
VETERINARY MICROBIOLOGY, 2001, 83 (02) : 121 - 136
[22] Development of a live attenuated antigenic marker classical swine fever vaccine
Holinka, L. G.
Fernandez-Sainz, I.
O'Donnell, V.
Prarat, M. V.
Gladue, D. P.
Lu, Z.
Risatti, G. R.
Borca, M. V.
VIROLOGY, 2009, 384 (01) : 106 - 113
[23] Classical swine fever (CSF) marker vaccine -: Trial I.: Challenge studies in weaner pigs
Uttenthal, Å
Le Potier, MF
Romero, L
De Mia, GM
Floegel-Niesmann, G
VETERINARY MICROBIOLOGY, 2001, 83 (02) : 85 - 106
[24] Classical swine fever (CSF) marker vaccine - Trial II. Challenge study in pregnant sows
Depner, KR
Bouma, A
Koenen, F
Klinkenberg, D
Lange, E
de Smit, H
Vanderhallen, H
VETERINARY MICROBIOLOGY, 2001, 83 (02) : 107 - 120
[25] Classical Swine Fever (CSF): a historical review of research and vaccine production on the Isle of Riems
Kaden, V
Riebe, B
BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2001, 114 (7-8): : 246 - 251
[26] Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination
Blome, Sandra
Aebischer, Andrea
Lange, Elke
Hofmann, Martin
Leifer, Immanuel
Loeffen, Willie
Koenen, Frank
Beer, Martin
VETERINARY MICROBIOLOGY, 2012, 158 (1-2) : 42 - 59
[27] Development of a classical swine fever subunit marker vaccine and companion diagnostic test
Moormann, RJM
Bouma, A
Kramps, JA
Terpstra, C
De Smit, HJ
VETERINARY MICROBIOLOGY, 2000, 73 (2-3) : 209 - 219
[28] Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination
de Smit, AJ
Bouma, A
de Kluijver, EP
Terpstra, C
Moormann, RJM
VETERINARY MICROBIOLOGY, 2001, 78 (04) : 307 - 317
[29] Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus
Renson, P.
Le Dimna, M.
Gabriel, C.
Levai, R.
Blome, S.
Kulcsar, G.
Koenen, F.
Le Potier, M. F.
RESEARCH IN VETERINARY SCIENCE, 2014, 96 (02) : 389 - 395
[30] Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain
Han, Yuying
Xie, Libao
Yuan, Mengqi
Ma, Yuteng
Sun, Huimin
Sun, Yuan
Li, Yongfeng
Qiu, Hua-Ji
VETERINARY MICROBIOLOGY, 2020, 247

← 1 2 3 4 5 →